Member Info for chasrutledge

Orph should not be on aim. I sold my shares in a different company (which was a safe investment) to top up here at 12.30. The company i sold, dropped in price after i got out, so happy with that.

Imutex’s proprietary peptide modelling platform could have possible uses in identifying a peptide for use in a Coronavirus vaccine by using the successful FLU-v vaccine but swapping out the universal flu peptide with a peptide specific to COVID-19. Open Orphan’s management team is optimistic about the potential to monetise these assets through licensing them to Big Pharma for further development.

https://www.nytimes.com/2020/07/07/health/novavax-coronavirus-vaccine-warp-speed.html

This Space. :-)

Hvivo hasn’t put all its eggs into one petri dish — it’s testing for a vaccine as well. This month, a batch of volunteers will quarantine for up to 16 days in the lab’s isolated private rooms, their every biochemical process monitored. That certainly puts a new spin on lockdown.

Not sure if it was posted already?
https://www.metro.news/connect-is-antibody-testing-really-a-passport-to-covid-freedom/2063740/amp/?__twitter_impression=true

I use the word Acacia now when i have a bad day. dam them. Sure give it maybe 8 days? One investor told me that at the rate of selling they may be out fully by 10th. Or quicker.

In addition, CHIM studies must take place in laboratories with rigorous isolation to ensure that the infection does not spread into the community................. Step in ORPH :-)

https://www.nih.gov/news-events/news-releases/nih-activ-working-group-weighs-role-human-challenge-studies-sars-cov-2-vaccine-development

Covid 19 human challenge study by New England Journal of medicine
https://www.nejm.org/doi/full/10.1056/NEJMp2020076

This will be an interesting week. I need coffee! ??

MosaiQ used by Open Orphan
https://quotientbd.com/covid-19

Detailed information on mms
https://en.m.wikipedia.org/wiki/M%26M's

Gregory Stoloff:- He initially concentrated on corporate finance and was involved in numerous mergers and acquisitions and structured finance with an emphasis on the healthcare industry, including mergers by GlaxoSmithKline, Aventis and Pfizer. Gregory then moved on to concentrate on project finance and was involved in financings for major pharmaceutical companies such as Roche, Merck and Novartis and across various other sectors. Gregory also has a wealth of experience in advising and working with medical research companies.
Novartis was mentioned by Cathal in an interview. I think he said 'Navartis if your listening, you know where we are.'

Have a read of the leadership portfolio for Imutex.
Interesting connection with different companies
https://imutex.com/index.php/leadership/

https://www.personneltoday.com/hr/caution-urged-over-reliance-on-covid-19-antibody-testing/

make that 8ish

50ma above 100ma.
Looking to buy in but cant get to phone yet.

https://www.brrmedia.co.uk/broadcasts/5ef1ebe44335ee062bd06144/copied-from-5eccea4031da814c9fc76193

Imutex setting up on Bloomberg.
https://www.bloomberg.com/profile/company/1398038D:LN